Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir from different manufacturers for chronic hepatitis B under National Procurement Policy
ChiCTR2000036417Phase 4Not yet recruiting
- Sponsor
- The First People's Hospital of Kunshan
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB) (2 arms), sponsored by The First People's Hospital of Kunshan. Primary endpoints: HBV-DNA, HBeAg and 1 more. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2000036417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036417.